Critical to global health and vaccination, adjuvants are substances added to vaccines to improves their efficacy. Adjuvance is a biopharmaceutical company dedicated to empowering global health through fundamental breakthroughs in vaccine adjuvant design and manufacturing. One of Adjuvance's key breakthroughs has been the development of Saponex, a synthetic and safer version of the adjuvant QS-21, derived from the bark of a rare South American tree.

Adjuvance approached Virgo to create a logo and brand identity to reflect its mission, the logotype referencing the origins of Saponex in the rare South American tree. Full case study forthcoming.